Gastrointestinal (GI) Cancer Clinical Trials & Research at St. Joseph Health Medical Group

Almost all gastric (stomach) cancers are adenocarcinomas (cancers that begin in cells that make and release mucus and other fluids). Other types of gastric cancer are gastrointestinal carcinoid tumors, gastrointestinal stromal tumors, and lymphomas. Gastric cancer is often diagnosed at an advanced stage because there are no early signs or symptoms.

St. Joseph Health Medical Group is currently enrolling patients for the following gastrointestinal cancer clinical trial:

Immunotherapy Plus Anti-hyaluronan for Relapsed or Refractory Gastric Adenocarcinoma Clinical Trial

  • Locally advanced or Stage IV (metastatic).
  • All patients receive treatment.
  • Patients must have failed at least one previous platinum-based chemotherapy prior to enrolling.
  • Patients need to be HA-high.
  • All patients are given pembrolizumab + PEGPH20.
  • More information about the study can be found at: www.halo101.com.
  • Main study doctor (Principal Investigator): Ian Anderson, MD.
  • For more information, please contact the lead coordinator, Tracy Foster, at (707) 521-3836 orTracy.Foster@stjoe.org.

Our Locations